Opinion: The Public Is Unified On Lowering Drug Prices. Why Are Leaders Settling For Less?
PhRMA regards drug price negotiation for Medicare as an existential threat to its business — potentially costing billions.
drug costs
States Step Up Push to Regulate Pharmacy Drug Brokers
More than 100 separate bills regulating pharmacy benefit managers that serve as conduits for drug manufacturers have been introduced in 42 states, including Oregon, this year,
Oregon Lawmakers Pump Money And Oversight Into Health Care
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Residents will have to wait to see whether the Oregon Legislature’s increased spending and regulation of the health care industry will yield results.
Many Health Plans Now Must Cover Full Cost of Expensive HIV Prevention Drugs
Starting this month, most people with private insurance will no longer have to decide whether they can afford to protect themselves against HIV.
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay for drugs.
2021 Health Plans Granted Leeway To Limit Consumers’ Benefit From Drug Coupons
Advocates say a new rule will make it harder for patients with conditions such as cancer and multiple sclerosis who rely on very expensive drugs to afford them.
PhRMA Files Suit Against Oregon's New Prescription Drug Pricing Laws
The drug company trade group PhRMA has filed a legal challenge to a pair of Oregon laws designed to curb prescription prices.
The Pharmaceutical Research and Manufacturers of America filed suit in Eugene against two bills that passed the Oregon Legislature with bipartisan support.
Tensions Mount In Legislature Over Bill Restricting Pharmacy Middlemen
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
SALEM – For six years, Oregon pharmacies have been lobbying the state Legislature to rein in fees imposed on them by pharmacy benefit managers, the third-party intermediaries that negotiate prices with drug manufacturers and prescription drug claims with insurers.
Pressure Builds To Cut Medicare Patients In On Prescription Deals
Medicare enrollees, who have watched their out-of-pocket spending on prescription drugs climb in recent years, might be in for a break.
Out-Of-Pocket Costs Often Keep Pricey New Cholesterol Drugs Out Of Reach, Study Finds
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients’ out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Pages
